Lyra Therapeutics, Inc. - COM (LYRA)

Historical Portfolio Holders from Q2 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
32.7M
Holdings value Q2 2024
$9.06M
Value change Q2 2024
-$111M
Grand Portfolio weight change Q2 2024
0%
Number of holders
49
Number of buys Q2 2024
11
Number of sells Q2 2024
-9
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 520K $134K -$306K $0.26 9
2024 Q2 32.7M $9.06M -$111M $0.28 50
2024 Q1 45.6M $283M +$21M $6.22 77
2023 Q4 42.4M $222M +$30M $5.24 61
2023 Q3 31.9M $125M -$8.07M $3.91 44
2023 Q2 33.7M $138M +$60.9M $4.11 38
2023 Q1 18.9M $38.1M -$359K $2.01 30
2022 Q4 19.1M $59.9M -$364K $3.14 34
2022 Q3 19.2M $96M -$619K $5.01 33
2022 Q2 19.3M $109M +$80.6M $5.65 31
2022 Q1 5.02M $20.2M -$475K $4.02 24
2021 Q4 5.13M $22.4M -$3.69M $4.36 31
2021 Q3 6.67M $60.8M -$2.65M $9.13 33
2021 Q2 6.98M $56M -$6.44M $8.03 38
2021 Q1 7.56M $87.6M -$11.8M $11.59 49
2020 Q4 8.6M $98M +$10.2M $11.40 43
2020 Q3 7.66M $85.7M +$6.83M $11.18 39
2020 Q2 7.04M $79.8M +$79.8M $11.34 43